Home / Health / Fatty Liver: The Silent Epidemic Affecting Millions
Fatty Liver: The Silent Epidemic Affecting Millions
20 Apr
Summary
- Fatty liver disease, now MASLD, affects one in five UK adults.
- Early stages are often silent with no obvious symptoms.
- Lifestyle factors like obesity and diet drive rising cases.
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly non-alcoholic fatty liver disease, affects approximately one in five people in the UK. This condition, often silent in its early stages, is increasingly linked to lifestyle factors rather than solely alcohol consumption. MASLD can be triggered by being overweight, Type 2 diabetes, poor diet, high cholesterol, and sedentary habits.
Recent data indicates a concerning four-fold increase in liver disease mortality in the UK over the past 50 years, with over 11,000 deaths annually. Alarmingly, one in ten children show early signs of MASLD. Preventable factors, including alcohol, obesity, and unhealthy diets, are implicated in 90 percent of these deaths.
Adopting healthier habits, such as weight loss, regular exercise, and significantly reducing sugar intake, can be crucial for managing and improving liver health. While there is no approved drug therapy specifically for MASLD, lifestyle modifications remain the most effective tools. Online risk checkers and open discussions with healthcare professionals can help individuals assess and address their liver health concerns.
